174 related articles for article (PubMed ID: 22039459)
1. Refinement of 1p36 alterations not involving PRDM16 in myeloid and lymphoid malignancies.
Duhoux FP; Ameye G; Lambot V; Herens C; Lambert F; Raynaud S; Wlodarska I; Michaux L; Roche-Lestienne C; Labis E; Taviaux S; Chapiro E; Nguyen-Khac F; Struski S; Dobbelstein S; Dastugue N; Lippert E; Speleman F; Van Roy N; De Weer A; Rack K; Talmant P; Richebourg S; Mugneret F; Tigaud I; Mozziconacci MJ; Laibe S; Nadal N; Terré C; Libouton JM; Decottignies A; Vikkula M; Poirel HA; ;
PLoS One; 2011; 6(10):e26311. PubMed ID: 22039459
[TBL] [Abstract][Full Text] [Related]
2. PRDM16 (1p36) translocations define a distinct entity of myeloid malignancies with poor prognosis but may also occur in lymphoid malignancies.
Duhoux FP; Ameye G; Montano-Almendras CP; Bahloula K; Mozziconacci MJ; Laibe S; Wlodarska I; Michaux L; Talmant P; Richebourg S; Lippert E; Speleman F; Herens C; Struski S; Raynaud S; Auger N; Nadal N; Rack K; Mugneret F; Tigaud I; Lafage M; Taviaux S; Roche-Lestienne C; Latinne D; Libouton JM; Demoulin JB; Poirel HA; ;
Br J Haematol; 2012 Jan; 156(1):76-88. PubMed ID: 22050763
[TBL] [Abstract][Full Text] [Related]
3. Translocation breakpoint mapping and sequence analysis in three monosomy 1p36 subjects with der(1)t(1;1)(p36;q44) suggest mechanisms for telomere capture in stabilizing de novo terminal rearrangements.
Ballif BC; Wakui K; Gajecka M; Shaffer LG
Hum Genet; 2004 Jan; 114(2):198-206. PubMed ID: 14579147
[TBL] [Abstract][Full Text] [Related]
4. FISH analysis of hematological neoplasias with 1p36 rearrangements allows the definition of a cluster of 2.5 Mb included in the minimal region deleted in 1p36 deletion syndrome.
Lahortiga I; Vázquez I; Belloni E; Román JP; Gasparini P; Novo FJ; Zudaire I; Pelicci PG; Hernández JM; Calasanz MJ; Odero MD
Hum Genet; 2005 May; 116(6):476-85. PubMed ID: 15744521
[TBL] [Abstract][Full Text] [Related]
5. Fluorescence in situ hybridization studies using BAC clones of the EVI1 locus in hematological malignancies with 3q rearrangements.
Madrigal I; Carrió A; Gómez C; Rozman M; Esteve J; Nomdedeu B; Campo E; Costa D
Cancer Genet Cytogenet; 2006 Oct; 170(2):115-20. PubMed ID: 17011981
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the recurrent translocation t(1;1)(p36.3;q21.1-2) in non-Hodgkin lymphoma by multicolor banding and fluorescence in situ hybridization analysis.
Lestou VS; Ludkovski O; Connors JM; Gascoyne RD; Lam WL; Horsman DE
Genes Chromosomes Cancer; 2003 Apr; 36(4):375-81. PubMed ID: 12619161
[TBL] [Abstract][Full Text] [Related]
7. Involvement of BCL6 in chromosomal aberrations affecting band 3q27 in B-cell non-Hodgkin lymphoma.
Chaganti SR; Chen W; Parsa N; Offit K; Louie DC; Dalla-Favera R; Chaganti RS
Genes Chromosomes Cancer; 1998 Dec; 23(4):323-7. PubMed ID: 9824205
[TBL] [Abstract][Full Text] [Related]
8. Heterogeneity in the breakpoints in balanced rearrangements involving band 12p13 in hematologic malignancies identified by fluorescence in situ hybridization: TEL (ETV6 ) is involved in only one half.
Sato Y; Bohlander SK; Kobayashi H; Reshmi S; Suto Y; Davis EM; Espinosa R; Hoopes R; Montgomery KT; Kucherlapati RS; Le Beau MM; Rowley JD
Blood; 1997 Dec; 90(12):4886-93. PubMed ID: 9389705
[TBL] [Abstract][Full Text] [Related]
9. Detection by fluorescence in situ hybridization of microdeletions at 1p36 in lymphomas, unidentified on cytogenetic analysis.
Rajgopal A; Carr IM; Leek JP; Hodge D; Bell SM; Roberts P; Horgan K; Bonthron DT; Selby PJ; Markham AF; MacLennan KA
Cancer Genet Cytogenet; 2003 Apr; 142(1):46-50. PubMed ID: 12660032
[TBL] [Abstract][Full Text] [Related]
10. Uncovering novel inter- and intrachromosomal chromosome 1 aberrations in follicular lymphomas by using an innovative multicolor banding technique.
Lestou VS; Gascoyne RD; Salski C; Connors JM; Horsman DE
Genes Chromosomes Cancer; 2002 Jun; 34(2):201-10. PubMed ID: 11979554
[TBL] [Abstract][Full Text] [Related]
11. Cryptic and partial deletions of PRDM16 and RUNX1 without t(1;21)(p36;q22) and/or RUNX1-PRDM16 fusion in a case of progressive chronic myeloid leukemia: a complex chromosomal rearrangement of underestimated frequency in disease progression?
Deluche L; Joha S; Corm S; Daudignon A; Geffroy S; Quief S; Villenet C; Kerckaert JP; Laï JL; Preudhomme C; Roche-Lestienne C
Genes Chromosomes Cancer; 2008 Dec; 47(12):1110-7. PubMed ID: 18767145
[TBL] [Abstract][Full Text] [Related]
12. Rearrangements of chromosome band 1p36 in non-Hodgkin's lymphoma.
Dave BJ; Hess MM; Pickering DL; Zaleski DH; Pfeifer AL; Weisenburger DD; Armitage JO; Sanger WG
Clin Cancer Res; 1999 Jun; 5(6):1401-9. PubMed ID: 10389925
[TBL] [Abstract][Full Text] [Related]
13. Identification of new translocations involving ETV6 in hematologic malignancies by fluorescence in situ hybridization and spectral karyotyping.
Odero MD; Carlson K; Calasanz MJ; Lahortiga I; Chinwalla V; Rowley JD
Genes Chromosomes Cancer; 2001 Jun; 31(2):134-42. PubMed ID: 11319801
[TBL] [Abstract][Full Text] [Related]
14. Follicular lymphoma grade 3B includes 3 cytogenetically defined subgroups with primary t(14;18), 3q27, or other translocations: t(14;18) and 3q27 are mutually exclusive.
Bosga-Bouwer AG; van Imhoff GW; Boonstra R; van der Veen A; Haralambieva E; van den Berg A; de Jong B; Krause V; Palmer MC; Coupland R; Kluin PM; van den Berg E; Poppema S
Blood; 2003 Feb; 101(3):1149-54. PubMed ID: 12529293
[TBL] [Abstract][Full Text] [Related]
15. Identification of breakpoint cluster regions at 1p36.3 and 3q21 in hematologic malignancies with t(1;3)(p36;q21).
Shimizu S; Suzukawa K; Kodera T; Nagasawa T; Abe T; Taniwaki M; Yagasaki F; Tanaka H; Fujisawa S; Johansson B; Ahlgren T; Yokota J; Morishita K
Genes Chromosomes Cancer; 2000 Mar; 27(3):229-38. PubMed ID: 10679911
[TBL] [Abstract][Full Text] [Related]
16. Molecular cytogenetic analysis of follicular lymphoma (FL) provides detailed characterization of chromosomal instability associated with the t(14;18)(q32;q21) positive and negative subsets and histologic progression.
Nanjangud G; Rao PH; Teruya-Feldstein J; Donnelly G; Qin J; Mehra S; Jhanwar SC; Zelenetz AD; Chaganti RS
Cytogenet Genome Res; 2007; 118(2-4):337-44. PubMed ID: 18000388
[TBL] [Abstract][Full Text] [Related]
17. Clinical and biological characteristics of adult de novo and secondary acute myeloid leukemia with balanced 11q23 chromosomal anomaly or MLL gene rearrangement compared to cases with unbalanced 11q23 anomaly: confirmation of the existence of different entities with 11q23 breakpoint.
Archimbaud E; Charrin C; Magaud JP; Campos L; Thomas X; Fière D; Rimokh R
Leukemia; 1998 Jan; 12(1):25-33. PubMed ID: 9436917
[TBL] [Abstract][Full Text] [Related]
18. Conventional cytogenetics and breakpoint distribution by fluorescent in situ hybridization in patients with malignant hemopathies associated with inv(3)(q21;q26) and t(3;3)(q21;q26).
De Braekeleer E; Douet-Guilbert N; Basinko A; Bovo C; Guéganic N; Le Bris MJ; Morel F; De Braekeleer M
Anticancer Res; 2011 Oct; 31(10):3441-8. PubMed ID: 21965759
[TBL] [Abstract][Full Text] [Related]
19. Monosomy 1p36 breakpoint junctions suggest pre-meiotic breakage-fusion-bridge cycles are involved in generating terminal deletions.
Ballif BC; Yu W; Shaw CA; Kashork CD; Shaffer LG
Hum Mol Genet; 2003 Sep; 12(17):2153-65. PubMed ID: 12915474
[TBL] [Abstract][Full Text] [Related]
20. New chromosome abnormalities and lack of BCL-6 gene rearrangements in Argentinean diffuse large B-cell lymphomas.
Cerretini R; Noriega MF; Narbaitz M; Slavutsky I
Eur J Haematol; 2006 Apr; 76(4):284-93. PubMed ID: 16519699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
